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A B S T R A C T
Background: Experimental evidence suggests that exposures to phthalates and bisphenols may interfere with
processes related to glucose and lipid metabolism, insulin sensitivity, and body weight. Few studies have con-
sidered the possible influence of chemical exposures during pregnancy on maternal weight gain or metabolic
health outcomes postpartum.
Objective: To examine the associations of early and mid-pregnancy bisphenol and phthalate urine concentrations
with maternal weight gain 6 years postpartum.
Methods: We analyzed urine samples for bisphenol, phthalate and creatinine concentrations from early and mid-
pregnancy in 1192 women in a large, population-based birth cohort in Rotterdam, the Netherlands, and ex-
amined postpartum weight gain using maternal anthropometrics before pregnancy and 6 years postpartum. We
have used covariate-adjusted linear regressions to evaluate associations of early and mid-pregnancy bisphenols
and phthalate metabolites with weight change. Mediator and interaction models have been used to assess the
role of gestational weight gain and breastfeeding, respectively. Sensitivity analysis is performed among women
without subsequent pregnancies.
Results: Among all 1192 mothers included in the analysis, each log unit increase in the average bisphenol A and
all assessed phthalate groupings were associated with increased maternal weight gain. As a proxy for phthalate
exposure, each log unit increase in averaged phthalic acid was associated with 734 g weight gain (95% CI
273–1196 g) between pre-pregnancy and 6 years postpartum. Mediation by gestational weight gain was not
present. Breastfeeding and ethnicity did not modify the effects. Stratification revealed these associations to be
strongest among overweight and obese women. Among women without subsequent pregnancies (n = 373)
associations of bisphenols, HMW phthalate metabolites and di-2-ethylhexylphthalate metabolites attenuated.
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T
For phthalic acid, LMW phthalate metabolites and di-n-octylphthalate metabolites associations increased.
Similarly to the whole group, stratification yielded significant results among overweight and obese women.
Discussion: In a large population-based birth cohort, early and mid-pregnancy phthalate exposures are associated
with weight gain 6 years postpartum, particularly among overweight and obese women. These data support
ongoing action to replace phthalates with safer alternatives.
1. Background
Prevalence rates of overweight and obesity among women are
staggering, reaching upwards of 40% worldwide, and current trends
suggest that these rates are increasing (Flegal et al., 2016). Pregnancy
represents a critical life course event for women that is associated with
physiologic and metabolic changes and substantial weight gain, all of
which may contribute to the development of overweight and obesity
among women (Rasmussen et al., 2010). Although lifestyle and beha-
vioral factors, notably diet and physical activity, are strong predictors
of retention of pregnancy-related weight gain (Amorim Adegboye and
Linne, 2013), exposures to other environmental factors, such as endo-
crine disrupting chemicals, may have a causal role (Heindel et al.,
2015). A growing body of evidence indicates that pregnancy is a period
of increased susceptibility to potentially long-term physiological
changes due to exposure to endocrine disrupting chemicals, with per-
sistent effects (Gore et al., 2015). Among the many changes that occur
during pregnancy, sex steroids generally increase throughout preg-
nancy. Sex steroids are involved in the complex regulation of appetite,
eating and energy metabolism. During pregnancy, remarkable physio-
logical adaptations of appetite and body composition occur
(Hirschberg, 2012). Dysregulation of sex steroids during pregnancy due
to exposure to environmental chemicals might lead to maternal weight
gain, which could persist into postpartum. Maternal fat accumulation
takes place mainly in the first two trimesters of pregnancy, which is
mainly the result of enhanced insulin sensitivity (Herrera and Ortega-
Senovilla, 2010). Peroxisome proliferator-activated receptor γ (PPARγ),
which is highly expressed in adipose tissue, has a key role in adipo-
genesis, lipid metabolism and insulin sensitivity (Medina-Gomez et al.,
2007). Enhanced activation of PPARγ by environmental chemicals
might lead to changes in adipose tissue function which might track into
postpartum. Pregnancy-related metabolic changes might affect the
metabolism of these chemicals, leading to increased biological avail-
ability or prolongation of exposure and effects (Clewell et al., 2008).
Phthalates and bisphenols, such as bisphenol A (BPA) and its re-
placements (e.g. bisphenol S (BPS)), are ubiquitous endocrine dis-
rupting chemicals that are used in various consumer, personal care, and
industrial products and are detectable in most humans (Philips et al.,
2017; Sathyanarayana, 2008). Experimental evidence demonstrated
that these chemicals may interfere with processes related to glucose and
lipid metabolism, energy balance, and insulin sensitivity, subsequently
influencing body weight and metabolic health through binding steroid
receptors and PPARs (Desvergne et al., 2009; Heindel et al., 2017;
Nunez et al., 2001; Philips et al., 2017; Wei et al., 2011). Among
pregnant and non-pregnant women, cross-sectional studies report po-
sitive associations of urinary concentrations of phthalates and BPA with
Body Mass Index (BMI) and waist circumference (Buser et al., 2014;
Carwile and Michels 2011; Hatch et al., 2008; Liu et al., 2017; Yaghjyan
et al., 2015). Additionally, a longitudinal analysis of the Nurses’ Health
Study found that higher baseline concentrations of BPA and specific
phthalate metabolites (phthalic acid, monobenzylphthalate (mBzP),
and butyl phthalates) were associated with modestly faster rates of
weight gain during a 10-year follow up (Song et al., 2014). In the
Women’s Health Initiative, researchers observed associations of several
phthalates with short term weight gain in postmenopausal women
(Díaz Santana et al., 2019). Obesogenic effects of bisphenols other than
BPA in women, specifically, have not been investigated, though it is
thought they have similar endocrine disrupting capabilities (Trasande
2017; Usman and Ahmad 2016).
Few studies have considered the possible influence of prenatal
chemical exposures on weight gain or metabolic health outcomes in
women, either during pregnancy or the postpartum. A recent study
investigating associations of prenatal phthalate exposure with maternal
weight gain up to 10 years postpartum observed that mono-3-carbox-
ypropylphthalates (mCPP) was associated with an higher weight gain
per year, while mono-benzylphthalate (mBzP) was associated with a
lower weight gain per year (Rodriguez-Carmona et al., 2019). In ro-
dents, low dose administration of BPA during pregnancy disrupted
normal pregnancy-induced insulin resistance, leading to higher body
weight, plasma insulin, leptin, and triglyceride levels and greater in-
sulin resistance during the postpartum period, as compared to controls
(Alonso-Magdalena et al., 2010). Similarly, female mice exposed to
environmentally relevant levels of dietary di-2-ethylhexyl phthalate
(DEHP) prior to pregnancy resulted in increased weekly food intake,
body weight, and visceral adipose tissue, as well as altered mRNA and
plasma levels of hormones related to fat metabolism (e.g. leptin and
adiponectin) compared to unexposed mice (Schmidt et al., 2012). In
women, monoethylphthalate (mEP) was associated with impaired glu-
cose tolerance and excessive gestational weight gain (James-Todd et al.,
2016), which is considered the strongest risk factor of postpartum
weight retention (Rong et al., 2015). Conversely, we previously re-
ported that higher maternal bisphenol urine concentrations in early
pregnancy were associated with reduced gestational weight gain in the
second half of pregnancy (Philips et al., 2019). These findings suggest
that prenatal chemical exposures may have a lasting influence on wo-
men’s weight and metabolic health. The pregnancy period is an im-
portant period with great opportunities for prevention.
In the current analysis, we utilize longitudinal data from women
participating in a large, population-based prospective birth cohort to
determine whether urinary concentrations of bisphenols and phthalate
metabolites measured during early and mid-pregnancy are associated
with weight gain between pre-pregnancy and 6 years postpartum.
2. Methods
2.1. Study design and population for analysis
The present study was embedded in the Generation R Study, a po-
pulation-based prospective cohort study from early pregnancy onward
(Kooijman et al., 2016). In total, 8879 women were enrolled between
2002 and 2006, 76% before gestational age of 18 weeks. The study has
been approved by the Medical Ethical Committee of the Erasmus
Medical Centre in Rotterdam and New York University School of
Medicine. Written consent was obtained from all participating women
(World Medical Association 2013).
Urine samples were collected at three time points in pregnancy
(< 18 weeks, 18–25 and>25 weeks) from 2004 onward (n = 2038).
Bisphenol and phthalate concentrations were measured among a sub-
group of 1405 women who delivered singletons in whom early and mid-
pregnancy urine samples were available and whose children also par-
ticipated in postnatal studies at 6 years of age. Of these, 1381 women
had both urine samples available for analysis. Another 189 women
were excluded due to missing information to estimate maternal weight
change. A total of 1192 participants were included in the final analytic
sample. Of these, only 373 women did not have another pregnancy
during the follow-up period.
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2.2. Urinary bisphenol and phthalate measurements
Bisphenol, phthalate and creatinine concentrations were measured
in spot urine sample obtained from each subject at the early and mid-
pregnancy visit (median gestational age 12.9 weeks [inter-quartile
range 12.1–14.5 weeks] and 20.4 weeks [inter-quartile range
19.9–20.9 weeks], respectively). All urine samples were collected be-
tween February 2004 and October 2005. Urine samples were collected
between 8 am and 8 pm in 100-mL polypropylene urine collection
containers, stored at 4 °C and transported within 24 h of receipt to the
STAR-MDC laboratory before being distributed manually in 25 mL
polypropylene vials to be frozen at −20 °C. The urine specimens were
shipped on dry ice in 4 mL polypropylene vials to the Wadsworth
Center, New York State Department of Health, Albany, New York for
analysis of bisphenol and phthalate concentrations. Quantitative de-
tection of phthalate metabolites was achieved utilizing a solid-phase
extraction (SPE) method followed by enzymatic deconjugation of the
glucuronidated phthalate monoesters coupled with high performance
liquid chromatography electrospray ionization-tandem mass spectro-
metry (HPLC-ESI-MS/MS), as previously used (Asimakopoulos et al.,
2016). Quantitative detection of bisphenols was achieved utilizing a
liquid–liquid extraction (LLE) method followed by enzymatic deconju-
gation of the glucuronidated bisphenols coupled with HPLC-ESI-MS/
MS. Assay precision is improved by incorporating isotopically-labeled
internal standards to allow for rapid detection. The majority of limits of
detection (LOD) for phthalates were in the range of 0.008–0.3 ng/ml.
The majority of LODs for bisphenols were in the range of 0.03 and
0.18 ng/ml. Samples were analyzed for creatinine using HPLC-ESI-MS/
MS, improved by incorporating 2D3-creatinine. Quantification of cali-
bration check standards resulted in an LOD of 0.30 ng/ml. Further
details on analysis methodology are provided elsewhere (Philips et al.,
2018).
Urinary bisphenols and phthalate metabolites were analyzed both
individually and in groups for data analysis. We grouped phthalate
metabolites according to their molecular weight categories. Phthalate
metabolites were only included in the phthalate groupings if detected
in>20% of the sample. The same applied for bisphenols. For in-
dividual compound analysis, compounds were only included if detected
in>50% of the sample in both pregnancy periods. Concentrations of
individual phthalate metabolites and groups represented by only one
metabolite, as well as individual bisphenols, were reported in ng/ml.
We calculated the weighted molar sums for groups representing total
bisphenols, low molecular weight (LMW) phthalates, high molecular
weight (HMW) phthalates, the intermediate molecular weight di-2-
ethylhexyl phthalate (DEHP), and di-n-octylphthalate (DNOP) using the
formula: ((concentration in ng/ml compound 1) * (1/molecular weight
compound 1) * (1/10^-3)) + ((concentration in ng/ml compound 2) * (1/
molecular weight compound 2) * (1/10^-3)) + etc., resulting in con-
centrations expressed in nmol/L. Phthalic acid (PA) was analyzed se-
parately as a proxy for total phthalate exposure (Bang du et al., 2011).
For bisphenol and phthalate concentrations below the LOD we sub-
stituted values with a LOD value divided by the square root of 2 (LOD/
√2), as performed earlier (Hornung and Reed 1990). Bisphenol and
phthalate compounds included in the weighted molar sums for early
and mid-pregnancy groupings are shown in Supplementary Table S1.
2.3. Maternal anthropometrics
Maternal height (cm) was measured at enrollment without shoes.
Information on maternal weight just before pregnancy was obtained by
questionnaire in early pregnancy. Self-reported maternal pre-pregnancy
weight was highly correlated with measured early pregnancy weight
(median gestational age 12.9 weeks [inter-quartile range
12.1–14.5 weeks]) (Spearman’s correlation coefficient 0.951). Weight at
6 years postpartum (median child age 5.87 years [inter-quartile range
5.79–5.97 years]) was measured without shoes and heavy clothing
during a visit at the research center. Maternal postpartum weight gain
was based on pre-pregnancy weight and calculated as: maternal weight
6 years postpartum – maternal pre-pregnancy weight. Body mass index
(BMI) (kg/m2) before pregnancy was calculated.
2.4. Covariates
Potential covariates, effect modifiers, and variables for sensitivity
analyses were selected based on previous research, literature review
and causal diagram (Supplementary Fig. S1) (Philips et al., 2018). All
potential covariates were checked for collinearity by using correlations
and collinearity diagnostics. Information on parity (primiparity/multi-
parity), educational level (low/high) and maternal ethnicity (Dutch or
European/Non-European) was obtained from the first questionnaire at
enrollment (median gestational age 12.9 weeks [inter-quartile range
12.1–14.5 weeks]). Low educational level was defined as no education,
or finished primary or secondary education. High educational level was
defined as finished higher professional education or university. We
considered maternal age at the 6 year postpartum visit as a covariate.
Information on pre-pregnancy weight (kg) was obtained from the first
questionnaire at enrollment. Information on postpartum smoking
(current/previously smoked/never) and maternal alcohol use during
pregnancy (yes/no) was assessed by questionnaire.
Maternal daily dietary intake was assessed at enrollment using a
modified version of the validated semi-quantitative food-frequency
questionnaire (FFQ) of Klipstein-Grobusch et al. (1998). The FFQ cov-
ered the average dietary intake over the previous three months, cov-
ering the dietary intake in the first trimester of pregnancy (Tielemans
et al., 2016). We used caloric intake derived from the FFQ as a covariate
in statistical analyses. Gestational weight gain was calculated by sub-
tracting pre-pregnancy weight from the last measured weight in preg-
nancy (median 30.2 weeks gestation, inter-quartile range
29.9–30.8 weeks). Breastfeeding was used continuously, did not have to
be exclusive and did only relate to the index pregnancy. Information on
subsequent pregnancies was determined from postnatal follow-up
questionnaires.
2.5. Statistical analysis
After description of the final analytic sample, qualitative compar-
ison was also made for sociodemographic and other relevant risk factors
between the final analytic sample and the population of women who
delivered live born singletons and had available weight data until
6 years postpartum. Description of the urinary concentrations of
phthalates and bisphenols revealed substantial right skew, requiring
log-transformation prior to inclusion in multivariable models. Urinary
concentrations of bisphenols and phthalates were converted to µg/g
(for individual compounds) or µmol/g (for compound groups) creati-
nine. Additionally, all models have been adjusted for creatinine con-
centration by adding creatinine concentrations as covariates (Method 6,
i.e. regression models with biomarker measures standardized for crea-
tinine that also include creatinine as a covariate (O'Brien et al., 2016)).
To evaluate the degree of potential confounding, we performed
univariate regressions of postpartum weight gain against potential so-
ciodemographic, lifestyle and dietary confounders. Separate regressions
were performed to evaluate changes in maternal weight in the period
from before pregnancy until 6 years postpartum in relationship to early
and mid-pregnancy urinary concentrations of phthalates, their meta-
bolites and bisphenols separately. Multivariable regressions controlled
for maternal age, parity, ethnicity, education, dietary caloric intake
during early pregnancy, pre-pregnancy BMI maternal smoking and al-
cohol during pregnancy. For analyses, bisphenol and phthalate urinary
concentrations (standardized for creatinine) in early and mid-preg-
nancy were averaged. Non-linear effects of averaged bisphenol and
phthalate urinary concentrations on postpartum weight gain were as-
sessed using quartiles. To investigate mediation by gestational weight
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gain, we used the bootstrap method according to Hayes using model 4
(i.e. for mediation analysis) obtaining 5000 bootstrap samples (Hayes
2013; Hayes and Rockwood 2017). To assess effect modification by
breastfeeding, pre-pregnancy BMI and ethnicity we tested interaction
terms and performed stratified analyses if the interaction p-value< 0.1.
We performed additional analyses to assess associations of individual
compounds with weight gain. These analyses include the confounder,
mediator and interaction models, for averaged individual phthalate
compounds. To examine potential confounding of the associations
among women who had subsequent pregnancies, we performed sensi-
tivity analyses among women who did not have any subsequent preg-
nancies.
Missing data of the covariates were imputed using multiple im-
putation by fully conditional specification (FCS), assuming missingness
at random (MAR). The percentage of missing values within the popu-
lation for analysis were lower than or equal to 15% except for daily
dietary caloric intake (23.7%) and breastfeeding (19.5%). Qualitative
comparison of patterns of missing values showed that missingness was
predominantly accounted for by other measured variables, assuming
MAR. To increase imputation precision, we have used all 1,406 parti-
cipants and both covariates and outcomes as predictors (Moons et al.,
2006). Five imputed datasets were created and pooled for analyses,
taking into account the within and between imputation variance ac-
cording to Rubin’s Rules (Rubin 1987). Imputation diagnostics were
checked for potential changes in distributions of imputed variables. We
did not observe any changes in distributions. All analyses were per-
formed using the Statistical Package of Social Sciences version 21.0 for
Windows (SPSS Inc, Chicago, IL, USA). Bootstrapping was performed
using PROCESS v3.3 for SPSS.
3. Results
3.1. Subject characteristics
Compared to the entire Generation R sample, the study population
generally was of a similar sociodemographic profile and prevalence of
other relevant risk factors for weight gain (Table 1 and Supplementary
Table S2). Urinary concentrations of bisphenols and phthalates were
similar in early and mid-pregnancy, with the exception of a qualita-
tively higher detection rate for bisphenols S and F, and for mono-hex-
ylphthalate (mHxP) and mono-2-heptylphthalate (mHpP) in early
pregnancy compared to mid-pregnancy (Table 2). Univariate regres-
sions (Supplementary Table S3) of postpartum weight gain against the
sociodemographic, lifestyle and dietary covariates revealed significant
associations with maternal age (inverse), pre-pregnancy BMI (inverse),
gestational weight gain (positive), parity (lower among multiparous
mothers), ethnicity (higher among non-Dutch/non-European women),
education (higher in lower education group), alcohol use (higher
among those reporting no consumption in pregnancy) and smoking
(higher among mothers who smoked during pregnancy). Also mid-
pregnancy creatinine urinary concentrations were associated with a
higher weight gain.
3.2. Maternal weight gain
Unadjusted for potential covariates, all averaged bisphenol and
phthalate groupings were associated with an increased maternal weight
gain (Supplementary Table S4). Among all 1,192 mothers included in
the analysis, each log unit increase in the average bisphenol A was
associated with 364 g weight gain (95% Confidence Interval (CI)
10–718 g) between pre-pregnancy and 6 years postpartum (Table 3).
PA and all assessed phthalate groupings were associated with maternal
weight gain. As a proxy for total phthalate exposure, each log unit in-
crease in averaged PA was associated with 734 g weight gain (95% CI
273–1196 g). DNOP metabolites were strongest associated with weight
gain (each log unit increase in averaged DNOP metabolites was
associated with 840 g weight gain (95% CI 347–1332 g). Assessment of
potential non-linear association averaged bisphenol and phthalate
concentrations using quartiles did not reveal any indications of non-
linearity (data not shown). Mediation analysis using bootstrapping did
not obtain a significant indirect effect (i.e. no mediation) via gestational
weight gain. No effect modification by breastfeeding or ethnicity was
observed, therefore, stratified models have not been performed (data
not shown). Interaction terms for pre-pregnancy BMI were p-value< 0.1
for total bisphenols and DNOP metabolites. Stratified analysis showed
no significant associations for total bisphenols, but each log unit in-
crease in averaged DNOP metabolites was associated with 671 g weight
gain (95% CI 226–1116 g) among normal weigh women and 3893 g
weight gain (95% CI 2–7784 g) among obese women (Supplementary
Table S5).
Further examination of individual phthalate urinary metabolites
showedassociations for all examined individual phthalate compounds
except for 2 DEHP metabolites, mono-(2-ethyl-5-hydroxyhexyl)phtha-
late (mEHHP) and mono-[(2-carboxymethyl)hexyl]phthalate (mCMHP)
(Supplementary Table S6). Monomethylphthalate (mMP) was strongest
associated with weight gain (per log unit averaged increase 856 g
weight gain [95% CI 433–1279 g]). Similarly to the groupings, gesta-





Maternal age at follow-up (years) 36.8 (4.7)
Missing NA












Dietary caloric intake during pregnancy 2077 (508)
Missing 282 (23.7)
Gestational weight gain (until late pregnancy) 10.3 (4.7)
Missing 5 (0.4)
Pre-pregnancy BMI (kg/m2)b 22.7 (20.8, 25.3)
Missing NA
Creatinine early pregnancy (μg/mL)b 1019 (486, 1656)
Missing NA






Alcohol consumption during pregnancy
No alcohol use 480 (40.3)
Alcohol use 635 (53.3)
Missing 77 (6.5)
Breastfeeding (months)b 3.5 (1.5, 6.5)
Missing 233 (19.5)
Maternal weight change (kg) 4.7 (7.2)
Missing NA
NA: not applicable.
a Values are means (standard deviation) or numbers of subjects (percentage).
b Median (IQR range).
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breastfeeding or ethnicity was found (data not shown). Significant in-
teraction was observed for pre-pregnancy BMI with mMP and mCPP.
Further stratification yielded significant results for mMP and mCPP
among obese women with an increased weight gain (for each log unit
increase of averaged compounds 3461 g [95% CI 232–6689 g] for mMP
and 3893 g weight gain [95% CI 2–7784 g] for mCPP) (data not shown).
3.3. Sensitivity analysis
Among women without subsequent pregnancies (n = 373) asso-
ciations of bisphenols, HMW phthalate metabolites and DEHP meta-
bolites attenuated (Table 4). For PA, LMW phthalate metabolites and
DNOP metabolites associations increased (per log unit increase of
averaged compounds 1193 g [95% CI 293–2092 g], 797 g [95%
186–1407 g] and 1007 g weight gain [95% CI 211–1803 g], respec-
tively). A consistent pattern was observed for individual phthalate
compounds, with similar to the whole group the strongest association
with weight gain for mMP (per log unit averaged increase 1378 g
weight gain [95% CI 608–2147 g]) (Supplementary Table S7). Gesta-
tional weight gain did not mediate the effects and no effect modifica-
tion by breastfeeding or ethnicity was observed (data not shown). We
observed effect modification by pre-pregnancy BMI of the associations
Table 2
Bisphenol and phthalate urinary concentrations (n = 1,192).
Early pregnancy
median GA 12.9 wks (IQR 12.1–14.5)
Mid-pregnancy
median GA 20.4 wks (IQR 19.9–20.9)
Median (IQR)
(ng/mL)




Percentage of values below the limit
of detection (LOD)
Total bisphenolsa 9.35 (3.53, 20.69) 6.29 (3.04, 13.71)
Bisphenol A (BPA) 1.67 (0.70, 3.63) 21.2 1.46 (0.74, 3.17) 6.7
Bisphenol S (BPS) 0.36 (0.17, 1.07) 32.0 0.24 (0.12, 0.49) 71.0
Bisphenol F (BPF) 0.58 (0.30, 1.31) 59.8 0.50 (0.31, 1.22) 88.3









Monomethylphthalate (mMP) 5.59 (2.76, 9.82) 0.2 3.46 (1.84, 6.21) 0.2





Mono-isobutylphthalate (mIBP) 20.97 (9.55, 45.43) 0.2 8.86 (4.58, 17.81) –
Mono-n-butylphthalate (mBP) 15.99 (7.02, 31.03) 0.8 9.66 (5.45, 18.97) –










16.04 (8.23, 31.25) 0.2 10.42 (5.75, 19.95) 0.1
Mono-(2-ethyl-5-hydroxyhexyl)phthalate
(mEHHP)
11.78 (5.76, 22.59) 0.2 5.57 (2.94, 10.65) 0.1
Mono-(2-ethyl-5-oxohexyl)phthalate (mEOHP) 7.67 (3.54, 15.28) – 7.43 (3.65, 16.11) –
Mono-[(2-carboxymethyl)hexyl]phthalate
(mCMHP)
14.03 (7.60, 26.25) 0.1 4.01 (2.28, 7.32) 0.3
Di-isononylphthalate (DINP)
Monoisononylphthalate (mINP) 0.74 (0.36, 1.93) 86.2 0.74 (0.36, 1.93) 98.7
Di-isodecylphthalate (DIDP)
Mono-(8-methyl-1-nonyl)phthalate (MIDP) 1.80 (1.28, 2.73) 92.0 1.80 (1.28, 2.73) 98.2
Di-n-octylphthalate (DNOP)a 5.77 (3.16, 10.81) 3.53 (2.05, 6.74)
Mono(3-carboxypropyl)phthalate (mCPP) 1.45 (0.80, 2.75) 0.3 0.89 (0.52, 1.69) –
Monooctylphthalate (mOP) 0.46 (0.34, 0.79) 90.3 0.46 (0.34, 0.79) 99.4
Mono-(7-carboxy-n-heptyl)phthalate (mCHpP) 0.11 (0.08, 0.13) 99.2 0.11 (0.08, 0.13) 100.0
Other high molecular weight metabolites
Monobenzylphthalate (mBzP) 6.35 (3.05, 12.55) 8.1 5.22 (2.26, 11.03) 1.5
Mono-hexylphthalate (mHxP) 0.33 (0.16, 0.62) 24.2 0.33 (0.16, 0.62) 98.7
Mono-2-heptylphthalate (mHpP) 1.09 (0.59, 2.33) 35.2 1.09 (0.58, 2.33) 96.7
Monocyclohexylphthalate (mCHP) 0.17 (0.09, 0.42) 80.9 0.17 (0.09, 0.42) 94.3
a Groups are molar concentrations in nmol/L with non-detectable levels of separate metabolites imputed as LOD/sqr(2). Separate metabolites are included only if
less than 80% of values was below the LOD. GA: gestational age.
Table 3
Multivariable associations of averaged early and mid-pregnancy bisphenol
and phthalate urine concentrations with maternal weight change from pre-
pregnancy up to until 6 years postpartum (n = 1,192).
Maternal weight change,
g (95% CI)
Total bisphenols 379 (−14, 772)
Bisphenol A 364 (10, 718)
Phthalic acid 734 (273, 1196)
LMW phthalate metabolites 678 (328, 1029)
HMW phthalate metabolites 724 (233, 1215)
DEHP metabolites 588 (115, 1061)
DNOP metabolites 840 (347, 1332)
Increases are per natural log unit increase in averaged early and mid-preg-
nancy urinary total bisphenols/BPA/Phthalic acid/LMW/HMW/DEHP/DNOP
metabolite concentrations per gram creatinine. All models were additionally
adjusted for early and mid-pregnancy creatinine concentrations (ng/mL).
Models have been adjusted for maternal age, parity, ethnicity, education,
dietary caloric intake during early pregnancy, pre-pregnancy BMI, maternal
smoking during pregnancy and maternal alcohol use during pregnancy.
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of total bisphenols, PA, LMW phthalate metabolites and DNOP meta-
bolites with weight gain (statistical interaction p-value<0.1) (data not
shown). Stratified analysis could not be performed for underweight
women due to an insufficient number of samples (n = 8). Stratification
yielded significant results for PA in the overweight group (per log unit
increase of averaged PA 3168 g weight gain [95% CI 802–5535 g]), for
LMW phthalate metabolites in the overweight and obese group (per log
unit increase of averaged LMW 1723 g [95% CI 185–3262 g] for
overweight and 5939 g weight gain [95% CI 1326–10553 g]) and for
DNOP metabolites in the obese group with increased weight gain (per
log unit increase of averaged DNOP 8184 g weight gain [95% CI
1916–14453 g]) (Supplementary Table S8). For individual phthalate
metabolites, effect modification was by pre-pregnancy BMI was ob-
served for mMP, mono-isobutylphthalate (mIBP), mono-n-butylphtha-
late (mBP), mCMHP, mono-(2-ethyl-5-oxohexyl)phthalate (mEOHP)
and mCPP (statistical interaction p-value<0.1) (data not shown). Fur-
ther stratification yielded significant results for mMP and mBP in both
overweight and obese women (respective weight gain for overweight
and obese women per log unit increase of averaged mMP 3143 g [95%
CI 832–5453 g] and 9052 g weight gain [95% 4663–13441 g] and for
mBP 2667 g [95% CI 519–4816 g] and 6237 g weight gain [95% CI
1932–10541 g]) (data not shown). Stratification of mCPP yielded the
same estimates as for DNOP.
4. Discussion
We identified associations of early and mid-pregnancy phthalate
exposure with weight gain 6 years postpartum. PA, LMW phthalate
metabolites and DNOP metabolites were associated with increased
weight gain. The associations of bisphenols and HMW phthalates atte-
nuated when women with subsequent pregnancies were excluded.
Stratification revealed these associations to be strongest among over-
weight and obese women.
4.1. Interpretation of main findings
The study findings build upon chiefly cross-sectional studies in
adults that suggest associations of phthalates with increases in body
mass (Buser et al., 2014; Carwile and Michels 2011; Hatch et al., 2008;
Liu et al., 2017; Yaghjyan et al., 2015). The only previous longitudinal
study in pregnant women found prenatal mCPP to be associated with a
300 g/year maternal weight gain during 10 years postpartum
(Rodriguez-Carmona et al., 2019). In contrast to our results, this study
found inverse associations for mBzP with maternal weight gain. A study
nested within the Nurses’ Health Study I and II intended to examine
type 2 diabetes in association with BPA and phthalate exposure iden-
tified 170–210 g/year greater weight gain among the most highly ex-
posed half of the samples for BPA, PA, mBzP and mBP (Song et al.,
2014). For mEP and DEHP metabolites non-monotonic associations
were observed. In this current study, we did not find any nonlinear
associations. Associations for BPA attenuated when women with sub-
sequent pregnancies were excluded. It is notable that we see similar
annual increases (~100–175 g/year) as in the Nurses’ Health Study
despite examining these exposures in a younger and purely pre-
menopausal population. These similar annual increases might suggest
that although pregnancy might be a period with increased susceptibility
to these compounds, the observed associations may also be independent
of pregnancy status. Additionally, our results suggest that overweight
and obese women are most vulnerable for effects of phthalate exposure
during pregnancy on long-term maternal weight gain. Women with
more adipose tissue may be more vulnerable for exposure to these
chemicals. However, we cannot exclude reversed causation by means
that these women might have a less healthy lifestyle leading to higher
bisphenol and phthalate exposure and weight increase independent of
exposure levels.
4.2. Strengths and limitations
A strength of our study is our use of two urine samples in pregnancy
to capture exposure more accurately. Bisphenol and phthalate meta-
bolites were measured in spot urine samples in early and mid-preg-
nancy and typically have half-lives of less than 24 h (Braun et al., 2013;
Mattison et al., 2014). A single spot urine sample for phthalates could
reasonably reflect exposure for up to three months (Hauser et al.,
2004), but bisphenols have a high temporal variability, even over the
day (Vernet et al., 2019). Within and between correlations for early and
mid-pregnancy compounds was low (Supplementary Table S9). This
non-differential misclassification is expected to lead to attenuation bias
in dose–response relationships. We therefore assume averaged models
to provide a better estimation of the result, especially for bisphenols. As
one exposure measurement may not fully characterize exposure levels,
we used averaged exposure measurements. Furthermore, our sensitivity
analysis excluding women with subsequent pregnancies limits possible
confounding. A weakness is the absence of serial measures of exposure
longitudinally that would permit evaluation whether chronic exposure
is more or less impactful than antecedent exposure years prior to weight
gain. Also information on postpartum exposure levels and weight be-
tween birth and 6 years postpartum is missing, disabling investigation
of associations independent of pregnancy status, persistence of ex-
posure levels and weight gain patterns. Our study population is ex-
clusively female, a similar limitation to the Nurses’ Health Study,
though it is somewhat more diverse in that substantial Surinames,
Turkish, Moroccan, Dutch Antillean and Cape Verdean populations are
included though we are also unable to evaluate effects in Hispanic
populations in whom obesity is especially prevalent (Jaddoe et al.,
2006). The present study relies on a single time point, in contrast to the
biannual evaluations performed in the Nurses’ Health Study (Song
et al., 2014). Residual confounding is always an alternative explanation
of findings such as ours, though we note careful control for multiple
potential confounders.
Phthalates are a heterogeneous group of synthetic chemicals with
diverse uses and effects. Obesogenic effects of bisphenols and phthalate
metabolites have been linked to peroxisome proliferator-activated re-
ceptor γ (PPARγ) activation (Hurst and Waxman 2003; Pereira-
Fernandes et al., 2013). PPARγ is expressed predominantly in adipose
tissue and to a lesser extent the macrophage and liver, acts as regulator
for adipocyte differentiation, lipid metabolism and reduces inflamma-
tion resulting in improved insulin sensitization. Di-2-ethylhex-
ylphthalate (DEHP), di-n-butylphthalate (DBP), di-iso-butylphthalate
(DiBP) and BPA have been reported as weak PPARγ activators, while
Table 4
Multivariable associations of averaged early and mid-pregnancy bisphenol
and phthalate urine concentrations with maternal weight change from pre-
pregnancy up to until 6 years postpartum in women without subsequent
pregnancies (n = 373).
Maternal weight change,
g (95% CI)
Total bisphenols 327 (−385, 1040)
Bisphenol A 221 (−445, 887)
Phthalic acid 1193 (293, 2092)
LMW phthalate metabolites 797 (186, 1407)
HMW phthalate metabolites 720 (−172, 1612)
DEHP metabolites 581 (−275, 1438)
DNOP metabolites 1007 (211, 1803)
Increases are per natural log unit increase in averaged early and mid-preg-
nancy urinary total bisphenols/BPA/Phthalic acid/LMW/HMW/DEHP/DNOP
metabolite concentrations per gram creatinine. All models were additionally
adjusted for early and mid-pregnancy creatinine concentrations (ng/mL).
Models have been adjusted for maternal age, parity, ethnicity, education,
dietary caloric intake during early pregnancy, pre-pregnancy BMI, maternal
smoking during pregnancy and maternal alcohol use during pregnancy.
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butylbenzylphthalate (BBP) and its main metabolite mBzP showed
strong activation of PPARγ. In contrast, we did not observe associations
of DEHP, BPA and mBzP with increased weight gain among women
without subsequent pregnancies. We did observe associations with in-
creased weight gain for mBP and mIBP, metabolites from DBP and
DiBP. An alternative explanation of the associations of LMW phthalates
may be by sex-steroid dysregulation which has been described (Grün
and Blumberg, 2009), though it should be noted these are thought to
have mainly anti-androgenic effects (Takeuchi et al., 2005). Further
studies are needed to evaluate these potential mechanisms, through
epigenetics, metabolomics and/or evaluation of sex steroids.
Diet has been considered the major source of phthalate exposure,
mainly due to contamination from processing and packaging (Schecter
et al., 2013; Schettler, 2006). Our previous study did not show strong
associations of nutrition related factors in the previous three months
with bisphenol and phthalate urine concentrations (Philips et al.,
2018). Given the short biological half-lives of bisphenols and phtha-
lates, this might have resulted in undetectable exposure–response as-
sociations. Together with the fact that the same study showed that
obese women had higher concentrations of bisphenols and phthalate
metabolites, we cannot rule out that higher bisphenol and phthalate
urinary concentrations reflect unhealthy nutrition patterns. A recent
review observed that healthier food choices were associated with lower
urinary bisphenol and phthalate metabolite concentrations among
pregnant women (Pacyga et al., 2019). We cannot rule out that women
with more fat tissue have higher adipose stores of lipophilic chemicals,
such as phthalates, and bisphenols to some extent. However, women
with more adipose tissue may be more vulnerable for exposure to these
chemicals or they might make less healthy food choices leading to a
higher bisphenol and phthalate exposure. A reduction of adipose tissue
through physical activity, dieting or weight loss surgery may decrease
the adipose stores of chemicals such as phthalates. On the other hand,
physical activity could influence the chemical metabolism, for example
by changes in the renal excretion. Dieting and weight loss surgery might
affect the associations as observed. Unfortunately, information on
physical activity, dieting and weight loss surgery was not available.
Smoking postpartum could not be included due to high correlation with
smoking during pregnancy and potential not-random missingness. We
cannot exclude that the missing information on these variables are a
source of residual confounding. Gestational weight gain has been cal-
culated from the last measured weight during pregnancy and pre-
pregnancy weight. Maximum pregnancy weight was self-reported, had
over 30% of missingness and was probably not missing at random.
Therefore, we have used the last measured weight during pregnancy.
Weight at late pregnancy and maximum pregnancy weight were highly
correlated (Spearman’s regression coefficient 0.954).
For the current study, we have used bisphenol and phthalate urinary
concentrations in early and mid-pregnancy. We hypothesize early and
mid-pregnancy compounds to be of the most importance, because the
majority of physiologic and metabolic changes occurs in these periods.
Mid-pregnancy bisphenol and phthalate urinary concentrations were
generally lower than in early pregnancy. Samples were batched ran-
domly, but analyzed in the order of pregnancy period. No batch effects
have been observed. During laboratory analysis, contamination that
arises from laboratory materials and solvents was monitored by the
analysis of procedural blanks. All values remained below the LOD and
were subtracted. In mid-pregnancy, maternal plasma volume has in-
creased largely. Therefore, we hypothesize that the decline in con-
centrations and detection rate reflects dilution due to increased ma-
ternal plasma volume in mid-pregnancy. We cannot exclude that this
decline is caused by metabolic changes and thereby might not represent
tissue exposure.
A common method to account for dilution of urinary chemical
concentrations is via creatinine adjustment (O'Brien et al., 2016). En-
dogenous creatinine clearance, measured by 24-hr urine collection,
remains the most precise estimation of the glomerular filtration rate in
pregnant women (Ahmed et al., 2009). However, creatinine might not
be a precise indicator of urinary dilution during periods of rapid growth
and metabolic change, such as pregnancy. A recent study suggested that
specific gravity adjustment is a better correction method in pregnant
women (MacPherson et al., 2018). Unfortunately, specific gravity
measurements were not available in our cohort. We have tested for the
robustness of results using several methods described by O’Brien et al.,
Using both the standardized biomarker measure as well as including
creatinine in the model as a covariate is hypothesized to control better
for variation due to hydration and to block back-door paths between
creatinine and risk factors related to both creatinine and disease as also
covariates are being adjusted for creatinine (O'Brien et al., 2016). In the
current study, mid-pregnancy creatinine concentrations were asso-
ciated with weight gain. Models with both standardized compounds
and creatinine concentrations as covariates had a better fit compared to
models with standardized compounds only.
Phthalate exposures have been estimated to contribute to 5900
newly incident cases of obesity in the US among adult women, and
another 53,900 in the EU (Attina et al., 2016; Legler et al., 2015). This
obesity also carries an economic toll, on the order of $1.7 billion an-
nually in the US and $20.8 billion in the EU. Exposures to phthalates
can be modified through behavioral modifications (Harley et al., 2016;
Rudel et al., 2011) as well as regulatory action. We note substantial
reductions in DEHP metabolites in the US between 2001 and 2010 (Zota
et al., 2014) due to additional regulatory attention that perhaps explain
the greater attributable obesity and costs in the EU compared to US
(Attina et al., 2016; Legler et al., 2015). This however does not rule out
effects on obesity from phthalates which are increasingly replacing
DEHP (e.g. di-isononylphthalate (DINP) and di-isodecylphthalate
(DIDP)), may have the same metabolic effects, and are associated with
insulin resistance and blood pressure in children (Attina and Trasande,
2015; Trasande and Attina, 2015). Additional studies will be needed
with newer populations to assess whether these replacements have the
same obesogenic effects.
4.3. Conclusion
In a large population-based birth cohort, early and mid-pregnancy
phthalate exposures are associated with weight gain 6 years post-
partum. These data support ongoing action to replace phthalates with
safer alternatives.
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